FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1762444524> ?p ?o ?g. }

• W1762444524 endingPage "1748" @default.
• W1762444524 startingPage "1735" @default.
• W1762444524 abstract "Treatment of patients with B-NHL with rituximab and CHOP has resulted in significant clinical responses. However, a subset of patients develops resistance to further treatments. The mechanism of unresponsiveness in vivo is not known. We have reported the development of rituximab-resistant clones derived from B-NHL cell lines as models to investigate the mechanism of resistance. The resistant clones exhibit hyper-activated survival/anti-apoptotic pathways and no longer respond to a combination of rituximab and drugs. Recent studies reported the therapeutic efficacy in mice bearing B-cell lymphoma xenografts following treatment with the anti-CD20-hIFNα fusion protein. We hypothesized that the fusion protein may bypass rituximab resistance and inhibit survival signaling pathways. Treatment of the rituximab-resistant clones with anti-CD20-hIFNα, but not with rituximab, IFNα, or rituximab+IFNα resulted in significant inhibition of cell proliferation and induction of cell death. Treatment with anti-CD20-hIFNα sensitized the cells to apoptosis by CDDP, doxorubicin and Treanda. Treatment with anti-CD20-hIFNα inhibited the NF-κB and p38 MAPK activities and induced the activation of PKC-δ and Stat-1. These effects were corroborated by the use of the inhibitors SB203580 (p38 MAPK) and Rottlerin (PKC-δ). Treatment with SB203580 enhanced the sensitization of the resistant clone by anti-CD20-hIFNα to CDDP apoptosis. In contrast, treatment with Rotterin inhibited significantly the sensitization induced by anti-CD20-hIFNα. Overall, the findings demonstrate that treatment with anti-CD20-hIFNα reverses resistance of B-NHL. These findings suggest the potential application of anti-CD20-hIFNα in combination with drugs in patients unresponsive to rituximab-containing regimens." @default.
• W1762444524 created "2016-06-24" @default.
• W1762444524 creator A5029894267 @default.
• W1762444524 creator A5031392396 @default.
• W1762444524 creator A5033964608 @default.
• W1762444524 creator A5055490703 @default.
• W1762444524 creator A5061022456 @default.
• W1762444524 creator A5067305483 @default.
• W1762444524 creator A5082889084 @default.
• W1762444524 date "2015-09-16" @default.
• W1762444524 modified "2023-10-18" @default.
• W1762444524 title "Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy" @default.
• W1762444524 cites W1509374036 @default.
• W1762444524 cites W1530104357 @default.
• W1762444524 cites W1565276921 @default.
• W1762444524 cites W1834505123 @default.
• W1762444524 cites W1978287208 @default.
• W1762444524 cites W1979840572 @default.
• W1762444524 cites W1982048708 @default.
• W1762444524 cites W1996710470 @default.
• W1762444524 cites W1997733155 @default.
• W1762444524 cites W2009512645 @default.
• W1762444524 cites W2013360427 @default.
• W1762444524 cites W2017358644 @default.
• W1762444524 cites W2018071905 @default.
• W1762444524 cites W2018553909 @default.
• W1762444524 cites W2031025766 @default.
• W1762444524 cites W2037876895 @default.
• W1762444524 cites W2038428454 @default.
• W1762444524 cites W2042108891 @default.
• W1762444524 cites W2045983585 @default.
• W1762444524 cites W2055585595 @default.
• W1762444524 cites W2056272003 @default.
• W1762444524 cites W2056521686 @default.
• W1762444524 cites W2056939983 @default.
• W1762444524 cites W2058983867 @default.
• W1762444524 cites W2066823421 @default.
• W1762444524 cites W2068044512 @default.
• W1762444524 cites W2072171359 @default.
• W1762444524 cites W2080501134 @default.
• W1762444524 cites W2083483697 @default.
• W1762444524 cites W2093392246 @default.
• W1762444524 cites W2099067831 @default.
• W1762444524 cites W2103565638 @default.
• W1762444524 cites W2108350814 @default.
• W1762444524 cites W2108446685 @default.
• W1762444524 cites W2112212243 @default.
• W1762444524 cites W2119197910 @default.
• W1762444524 cites W2136846143 @default.
• W1762444524 cites W2138916760 @default.
• W1762444524 cites W2142287416 @default.
• W1762444524 cites W2143088762 @default.
• W1762444524 cites W2147139550 @default.
• W1762444524 cites W2150040388 @default.
• W1762444524 cites W2168508518 @default.
• W1762444524 cites W219130964 @default.
• W1762444524 cites W2316354035 @default.
• W1762444524 cites W2416532890 @default.
• W1762444524 cites W2976680230 @default.
• W1762444524 cites W4211249224 @default.
• W1762444524 cites W65867874 @default.
• W1762444524 cites W2149160944 @default.
• W1762444524 doi "https://doi.org/10.3892/ijo.2015.3170" @default.
• W1762444524 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4735703" @default.
• W1762444524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26398317" @default.
• W1762444524 hasPublicationYear "2015" @default.
• W1762444524 type Work @default.
• W1762444524 sameAs 1762444524 @default.
• W1762444524 citedByCount "15" @default.
• W1762444524 countsByYear W17624445242016 @default.
• W1762444524 countsByYear W17624445242017 @default.
• W1762444524 countsByYear W17624445242019 @default.
• W1762444524 countsByYear W17624445242021 @default.
• W1762444524 countsByYear W17624445242022 @default.
• W1762444524 countsByYear W17624445242023 @default.
• W1762444524 crossrefType "journal-article" @default.
• W1762444524 hasAuthorship W1762444524A5029894267 @default.
• W1762444524 hasAuthorship W1762444524A5031392396 @default.
• W1762444524 hasAuthorship W1762444524A5033964608 @default.
• W1762444524 hasAuthorship W1762444524A5055490703 @default.
• W1762444524 hasAuthorship W1762444524A5061022456 @default.
• W1762444524 hasAuthorship W1762444524A5067305483 @default.
• W1762444524 hasAuthorship W1762444524A5082889084 @default.
• W1762444524 hasBestOaLocation W17624445241 @default.
• W1762444524 hasConcept C18031839 @default.
• W1762444524 hasConcept C203014093 @default.
• W1762444524 hasConcept C2779338263 @default.
• W1762444524 hasConcept C2779725641 @default.
• W1762444524 hasConcept C2780653079 @default.
• W1762444524 hasConcept C502942594 @default.
• W1762444524 hasConcept C71924100 @default.
• W1762444524 hasConcept C86803240 @default.
• W1762444524 hasConcept C98274493 @default.
• W1762444524 hasConceptScore W1762444524C18031839 @default.
• W1762444524 hasConceptScore W1762444524C203014093 @default.
• W1762444524 hasConceptScore W1762444524C2779338263 @default.
• W1762444524 hasConceptScore W1762444524C2779725641 @default.
• W1762444524 hasConceptScore W1762444524C2780653079 @default.

• next